SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-007812
Filing Date
2019-05-03
Accepted
2019-05-03 17:15:53
Documents
4
Period of Report
2019-05-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k050319_chinasxtpharma.htm 6-K 34783
2 FORM OF SERIES A SENIOR CONVERTIBLE NOTET, AS AMENDED f6k050319ex4-1_chinasxt.htm EX-4.1 312937
3 FORM OF SERIES B SENIOR SECURED CONVERTIBLE NOTE, AS AMENDED f6k050319ex4-2_chinasxt.htm EX-4.2 332316
4 AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT, DATED MAY 2, 2019, BY AND AMON f6k050319ex10-1_chinasxt.htm EX-10.1 49040
  Complete submission text file 0001213900-19-007812.txt   730061
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 19797231
SIC: 2834 Pharmaceutical Preparations